2-(2-methoxy-4-(1-methylpiperidin-3-yl)phenylamino)-9-methyl-5H-benzo[d]pyrimido[4,5-f][1,3]diazepin-6(7H)-one

ID: ALA4777299

PubChem CID: 162643395

Max Phase: Preclinical

Molecular Formula: C25H28N6O2

Molecular Weight: 444.54

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(C2CCCN(C)C2)ccc1Nc1ncc2c(n1)-c1ccc(C)cc1NC(=O)N2

Standard InChI:  InChI=1S/C25H28N6O2/c1-15-6-8-18-20(11-15)28-25(32)29-21-13-26-24(30-23(18)21)27-19-9-7-16(12-22(19)33-3)17-5-4-10-31(2)14-17/h6-9,11-13,17H,4-5,10,14H2,1-3H3,(H,26,27,30)(H2,28,29,32)

Standard InChI Key:  NGRVWRKSYIUGNZ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   24.1470   -1.7045    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.1459   -2.5240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8539   -2.9330    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.8521   -1.2956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5638   -2.5250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5607   -1.7009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2058   -1.1790    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.0136   -1.3541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3750   -2.0976    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.0228   -2.8479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2177   -3.0357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9792   -3.8253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5448   -4.4279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3521   -4.2356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5868   -3.4462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5184   -0.7115    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.4378   -2.9321    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.4372   -3.7493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7290   -4.1558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7280   -4.9722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4360   -5.3822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1463   -4.9697    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1438   -4.1547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4364   -6.1994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7263   -6.6051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7247   -7.4187    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.4309   -7.8307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1402   -7.4230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1433   -6.6032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9138   -4.8291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0221   -3.7458    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.0236   -2.9287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0157   -7.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  5  2  0
  6  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  5 11  1  0
  7  8  1  0
  8  9  1  0
 10  9  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  8 16  2  0
  2 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 21 24  1  0
 24 25  1  0
 24 29  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 14 30  1  0
 19 31  1  0
 31 32  1  0
 26 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4777299

    ---

Associated Targets(Human)

TNK2 Tclin Tyrosine kinase non-receptor protein 2 (2836 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BaF3 (4657 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 444.54Molecular Weight (Monoisotopic): 444.2274AlogP: 4.97#Rotatable Bonds: 4
Polar Surface Area: 91.41Molecular Species: BASEHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.56CX Basic pKa: 8.86CX LogP: 4.30CX LogD: 2.83
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.53Np Likeness Score: -0.83

References

1. Li Z,Powell CE,Groendyke BJ,Gero TW,Feru F,Feutrill J,Chen B,Li B,Szabo H,Gray NS,Scott DA.  (2020)  Discovery of a series of benzopyrimidodiazepinone TNK2 inhibitors via scaffold morphing.,  30  (19): [PMID:32739400] [10.1016/j.bmcl.2020.127456]

Source